Medicine News and Research

RSS

Study: Liver transplants from drug overdose donors increased in the pandemic's first year

Liver transplants from drug overdose donors rose significantly in the pandemic's first year, helping keep the number of liver transplants in the U.S. stable despite COVID-19 disruptions, according to a study to be presented at Digestive Disease Week 2022.

23 May 2022

Taste buds can be restrained to enjoy low sodium diet

A taste adaptation intervention lowers salt intake and increases enjoyment of a sodium restricted diet in patients with hypertension, according to a small study presented at ACNAP-EuroHeartCare Congress 2022, a scientific congress of the European Society of Cardiology.

23 May 2022

Cannabis users need higher levels of sedation during gastric endoscopies

Patients who use cannabis required higher levels of sedation during gastric endoscopies than non-users, according to research to be presented at Digestive Disease Week 2022.

23 May 2022

Custom caskets for kids look like something you ‘would see in a child’s room’

Calyia Stringer had a smile on her face the day she posed for a photo with a yellow flower in her hand. The toddler beamed with pride as she showed off the bloom before handing it to her godmother, Jatoria Foster.

23 May 2022

Pfizer COVID-19 vaccine-associated tinnitus responds to transcranial magnetic stimulation

Pfizer-BioNTech COVID-19 vaccine-associated tinnitus was relieved with a brief course of Transcranial Magnetic Stimulation treatment.

23 May 2022

Voice analysis app predicts most cases of worsening heart failure in advance

A voice analysis app used by heart failure patients at home recognizes fluid in the lungs three weeks before an unplanned hospitalization or escalation in outpatient drug treatment. The late breaking research is presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology.

22 May 2022

Even safe levels of alcohol consumption may harm the heart

Levels of alcohol consumption currently considered safe by some countries are linked with development of heart failure, according to research presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology.

22 May 2022

Olverembatinib a potent inhibitor of Omicron NTD-mediated cytokine release

Researchers determine whether mutations in the Omicron NTD influence its potential to stimulate myeloid cells and enhance inflammatory cytokine release.

22 May 2022

Unmarried heart failure patients lack confidence to manage their condition, study says

Unmarried heart failure patients appear less confident in managing their condition and more socially limited compared to their married counterparts, according to research presented today at Heart Failure 2022, a scientific congress of the European Society of Cardiology.

22 May 2022

High air pollution may increase risk for life-threatening arrhythmias

Life-threatening arrhythmias are more common on days with highly polluted air, according to research presented today at Heart Failure 2022, a scientific congress of the European Society of Cardiology.

22 May 2022

Higher excess mortality found in Massachusetts during Omicron period than the Delta period

The COVID-19 pandemic has led to excess deaths -; a higher number of fatalities than would be expected over a given period.

22 May 2022

Montefiore Einstein Cancer Center partners with the Price Family Foundation to advance cancer equity

The National Cancer Institute-designated Montefiore Einstein Cancer Center (MECC) has partnered with the Price Family Foundation to fund eight research teams developing novel cancer therapies and improving cancer outcomes for historically marginalized communities in the Bronx.

20 May 2022

Pioneering study could transform the treatment landscape for babies with infantile spasms

Infantile spasm (IS) is a severe epileptic syndrome of infancy and accounts for 50% of all epilepsy cases that occur in babies during the first year of life.

20 May 2022

New analysis finds increase in success and efficiency of chronic total occlusion percutaneous coronary intervention

A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion Intervention; www.progresscto.org), an international multi-center registry of chronic total occlusion (CTO) percutaneous coronary intervention (PCI), was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

20 May 2022

Study finds no difference in survival between patients treated with paclitaxel drug-coated devices and non-DCDs

New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD) study were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

20 May 2022

APOB-specific T cells may contribute to inflammation and further the progression of atherosclerosis

Preventing atherosclerosis, the underlying cause of heart disease, means scientists need to understand how immune cells drive inflammation in the arteries.

20 May 2022

Discoveries may lead to new ways to treat patients with Allan-Herndon-Dudley syndrome

Two recent discoveries co-led by scientists at Cedars-Sinai may help lead to new ways to treat patients with Allan-Herndon-Dudley syndrome (AHDS), a brain development disorder that causes severe intellectual disability and problems with movement.

20 May 2022

Liver acuity circle allocation policy associated with procurement delays

A national policy change to facilitate the broader sharing of donor livers through "acuity circles" has resulted in procurement delays, according to a researcher at the University of Miami Miller School of Medicine.

20 May 2022

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health awarded the UNC Gillings School of Global Public Health a $65 million grant establishing an Antiviral Drug Discovery Center to develop oral antivirals that can combat pandemic-level viruses like COVID-19.

20 May 2022

Molecular target discovery opens new pathways for developing effective anti-angiogenic cancer therapy

Researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute have identified a new molecular drug target that could result in new cancer drugs with fewer side effects.

20 May 2022

Medicine News and Research

Study: Liver transplants from drug overdose donors increased in the pandemic's first year

Taste buds can be restrained to enjoy low sodium diet

Cannabis users need higher levels of sedation during gastric endoscopies

Custom caskets for kids look like something you ‘would see in a child’s room’

Pfizer COVID-19 vaccine-associated tinnitus responds to transcranial magnetic stimulation

Voice analysis app predicts most cases of worsening heart failure in advance

Even safe levels of alcohol consumption may harm the heart

Olverembatinib a potent inhibitor of Omicron NTD-mediated cytokine release

Unmarried heart failure patients lack confidence to manage their condition, study says

High air pollution may increase risk for life-threatening arrhythmias

Higher excess mortality found in Massachusetts during Omicron period than the Delta period

Montefiore Einstein Cancer Center partners with the Price Family Foundation to advance cancer equity

Pioneering study could transform the treatment landscape for babies with infantile spasms

New analysis finds increase in success and efficiency of chronic total occlusion percutaneous coronary intervention

Study finds no difference in survival between patients treated with paclitaxel drug-coated devices and non-DCDs

APOB-specific T cells may contribute to inflammation and further the progression of atherosclerosis

Discoveries may lead to new ways to treat patients with Allan-Herndon-Dudley syndrome

Liver acuity circle allocation policy associated with procurement delays

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

Molecular target discovery opens new pathways for developing effective anti-angiogenic cancer therapy

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News